West China Fourth Hospital of Sichuan University
Welcome,         Profile    Billing    Logout  
 1 Trial 
6 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Xu, Jian
NCT05830500: Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma

Recruiting
4
360
RoW
Anlotinib Hydrochloride Capsule
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Medullary Thyroid Cancer
06/27
12/28
ALKIVIA, NCT05523167 / 2021-001277-23: A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants with Active Idiopathic Inflammatory Myopathy.

Recruiting
2/3
240
Europe, Canada, Japan, US, RoW
EFG PH20 SC, PBO
argenx, argenx BV
Active Idiopathic Inflammatory Myopathy, Myositis, Dermatomyositis, Polymyositis, Immune-Mediated Necrotizing Myopathy, Antisynthetase Syndrome
12/26
02/27
SIRIUS, NCT04582136: Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus

Recruiting
2
146
RoW
Sirolimus, rapamycin, Placebo
Chinese SLE Treatment And Research Group, Beijing Municipal Science & Technology Commission, North China Pharmaceutical Group Corporation
Systemic Lupus Erythematosus
10/24
05/25
NCT05849727: A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis

Recruiting
2
180
RoW
TQH3821 tablets 200 mg, TQH3821 tablets matching placebo
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Rheumatoid Arthritis
06/24
12/24
PALIZADE, NCT05781750: A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis

Suspended
2
279
Europe, US, RoW
zetomipzomib, KZR-616, placebo, matching placebo
Kezar Life Sciences, Inc.
Lupus Nephritis
05/26
07/26
NCT05227677: Value of Glycated Albumin in Intervention of Glycemic Control in Chinese Patients With Type 2 Diabetes

Active, not recruiting
N/A
200
RoW
GA guided anti-diabetic therapy adjustment, current guidelines to adjust treatment
Asahi Kasei Pharma Corporation
Type 2 Diabetes Mellitus
08/24
12/24

Download Options